🇺🇸 FDA

Drug profile · INN

delgocitinib

ANZUPGO

FDA: approved EMA: approved PMDA: approved D11AH11
US status
approved
Patents linked
0
News articles
0

Quick answer

delgocitinib (ANZUPGO) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN delgocitinib
Brand ANZUPGO
Route TOPICAL
Formulation CREAM
ATC code D11AH11

Frequently asked questions

What is delgocitinib?

delgocitinib (ANZUPGO) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for delgocitinib?

ANZUPGO is a marketed brand name for delgocitinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of delgocitinib?

delgocitinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.